Drug Profile
Somatropin - Dong-A
Alternative Names: DA-3002; Growtropin; Growtropin II; Growtropin-AQ; hGH-Dong-A; Human growth hormone-Dong-ALatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Dong-A Pharmaceutical
- Developer Dong-A ST
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Short stature
Most Recent Events
- 23 Mar 2019 Efficacy and adverse event data from a phase III trial in Short stature (In children, associated with Turner syndrome) presented at the 101st Annual Meeting of the Endocrine Society (ENDO,
- 01 Feb 2016 Dong-A Pharmaceutical initiates a phase III trial for Short stature (In children, In adolescents; associated with small for gestational age at birth) in South Korea (Parenteral, Injection) (NCT02770157)
- 28 Feb 2013 Dong-A Pharmaceutical initiates enrolment in a phase III trial for Short stature in children (associated with Turner's syndrome) in South Korea (NCT01813630)